Candel Therapeutics Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

623.53M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	-	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	125.00K	-	-
Dec 31, 2021	125.00K	-	-
Dec 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

CADL News

1 day ago - Candel Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
3 days ago - Candel Therapeutics publishes pivotal Phase 3 data for Aglatimagene - TheFly
3 days ago - Candel Therapeutics Announces Publication in The Lancet Oncology of Pivotal Phase 3 Data Demonstrating Significant Improvement in Disease-Free Survival with Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer - GlobeNewsWire
4 days ago - Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
16 days ago - Candel Therapeutics Transcript: Stifel 2026 Targeted Oncology Virtual Forum - Transcripts
18 days ago - Candel Therapeutics price target raised to $9 from $7 at BofA - TheFly
21 days ago - Candel Therapeutics Reports Extended Clinical Benefit Over Multiple Clinical Endpoints in Patients from Phase 3 Trial of Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer Under Prolonged Follow-up at AUA 2026 Annual Meeting - GlobeNewsWire
21 days ago - Candel Therapeutics Transcript: Study result - Transcripts

More News